Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use
Sebastian Hübner, Eline Haijen, Mendel Kaelen, Robin Carhart-Harris, Hannes Kettner
Journal of Medical Internet Research May 4, 2021 DOI: 10.2196/25973 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Prospective observational study Longitudinal Peer reviewed |
|---|---|
| Sample size | 654 |
| Population | Adults enrolled in a web-based prospective study on psychedelic use |
| Duration | 4 weeks post experience |
| Keywords | Attrition Health psychology Logistic regression Personality Conscientiousness Selection bias Clinical psychology Extraversion and introversion |
| Citations | 23 |
| Key findings | Younger age, lower education, higher extraversion, and lower conscientiousness predicted study dropout, while baseline attitudes toward psychedelics and acute challenging experiences did not. |
Abstract
Background: The resurgence of research and public interest in the positive psychological effects of psychedelics, together with advancements in digital data collection techniques, have brought forth a new type of research design, which involves prospectively gathering large-scale naturalistic data from psychedelic users; that is, before and after the use of a psychedelic compound. A methodological limitation of such studies is their high attrition rate, particularly owing to participants who stop responding after initial study enrollment. Importantly, study dropout can introduce systematic biases that may affect the interpretability of results.
Objective: Based on a previously collected sample (baseline n=654), here we investigated potential determinants of study attrition in web-based prospective studies on psychedelic use.
Methods: Logistic regression models were used to examine demographic, psychological trait and state, and psychedelic-specific predictors of dropout. Predictors were assessed 1 week before, 1 day after, and 2 weeks after psychedelic use, with attrition being defined as noncompletion of the key endpoint 4 weeks post experience.
Results: Predictors of attrition were found among demographic variables including age (β=0.024; P=.007) and educational levels, as well as personality traits, specifically conscientiousness (β=–0.079; P=.02) and extraversion (β=0.082; P=.01). Contrary to prior hypotheses, neither baseline attitudes toward psychedelics nor the intensity of acute challenging experiences were predictive of dropout.
Conclusions: The baseline predictors of attrition identified here are consistent with those reported in longitudinal studies in other scientific disciplines, suggesting their transdisciplinary relevance. Moreover, the lack of an association between attrition and psychedelic advocacy or negative drug experiences in our sample contextualizes concerns about problematic biases in these and related data.
Citations in the library
Cited by 21
- Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology January 5, 2022
- Case analysis of long-term negative psychological responses to psychedelics Scientific Reports September 25, 2023
- Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. Journal of Psychopharmacology August 1, 2022
- Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample Frontiers in Psychiatry June 29, 2021
- Psychiatric risks for worsened mental health after psychedelic use. Journal of Psychopharmacology March 4, 2024
and 16 more in the library
Cites 30
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
and 25 more in the library